It is known that ICAM-1 can be aberrantly expressed in CRC and suppress cancer progression via activation of the host immune surveillance system and prevention of cells from detaching from the primary tumor mass and thus attenuate or eliminate metastasis [6,7]. This evidence concerns the gene ICAM1 and neoplasm.